A mood of uncertainty hangs over India’s pharmaceutical sector as US President Donald Trump’s latest tariff threats have unsettled investors and policymakers alike.
But behind closed doors, a tentative deal on digital trade and quiet backchannel negotiations are giving hope to markets and manufacturers in both of the world’s most populous democracies.
“There appears to be recognition that the US needs to lower the rhetoric,” said foreign policy analyst Vivek Mishra, deputy director of the…
We understand Legal Issues in Asia